© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction
aDepartment of Pharmacology, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
bDepartment of Organ Pathophysiology and Internal Medicine, Tokyo University Hospital, Tokyo 113-8655, Japan
* Corresponding author. Tel.: +81-426-76-4583; fax: +81-426-76-5560. takeos{at}ps.toyaku.ac.jp
Objective: Genetic defects in several sarcoglycans (SGs) and dystrophin (Dys) play a critical role in cardiomyopathy. The present study was designed to determine whether changes in SGs and Dys might occur in animals with chronic heart failure (CHF) induced by acute myocardial infarction (AMI), which have no genetic defects. Methods: AMI was induced by the left coronary artery ligation (CAL) in rats. The hemodynamic parameters of the 2- and 8-week CAL (2w- and 8w-CAL) rats were measured and the myocardial SGs, Dys, calpain, and calpastatin levels were determined by the Western blot method. Myocardial calpain-like protease activity was evaluated as caseinolysis activity. Results: Increases in left ventricular end-diastolic pressure (LVEDP) and right ventricular systolic pressure, and a decrease in ±dP/dt were observed at the 2nd week, whereas cardiac output index (COI) was preserved. In contrast, the 8w-CAL rats showed a further increment in LVEDP with low COI. 
-SG of the viable left ventricle (LV), and septum (Sep) of the 8w-CAL rat decreased (60–70% of the control). The - and β-SGs of the right ventricle (RV) of the 2w- and 8w-CAL rats were reduced, while 
- and 
-SGs in the three regions did not change significantly. Dys in the viable LV and RV of the 8w-CAL rat decreased (75% of the control). The amount of m-calpain in the three regions of the 2w- and 8w-CAL rats increased (140–200% of the control), whereas the endogenous calpain inhibitor, calpastatin, did not change significantly. The in vitro degradation studies using purified m-calpain or cytosolic fractions of the 8w-CAL rat heart suggested a reduction in SGs and Dys by calpain. Conclusion: The results suggest that a decrease in SGs and Dys may play an important role in the pathophysiology of CHF following AMI.
KEYWORDS Calpain; Dystrophin; Heart failure; Hemodynamics; Sarcoglycan
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Honda, F. Masui, N. Kanzawa, T. Tsuchiya, and T. Toyo-oka Specific knockdown of m-calpain blocks myogenesis with cDNA deduced from the corresponding RNAi Am J Physiol Cell Physiol, April 1, 2008; 294(4): C957 - C965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shojima, N. Hayashida, A. Nishi, K. Takagi, H. Hori, K. Yoshikawa, and S. Aoyagi Effects of nicorandil preconditioning on membrane dystrophin. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 472 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Wilding, C. A. Lygate, K. E. Davies, S. Neubauer, and K. Clarke MLP accumulation and remodelling in the infarcted rat heart Eur J Heart Fail, June 1, 2006; 8(4): 343 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takahashi, K. Tanonaka, H. Yoshida, R. Oikawa, M. Koshimizu, T. Daicho, T. Toyo-oka, and S. Takeo Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart Cardiovasc Res, February 1, 2005; 65(2): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kido, H. Otani, S. Kyoi, T. Sumida, H. Fujiwara, T. Okada, and H. Imamura Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H81 - H90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Toyo-Oka, T. Kawada, J. Nakata, H. Xie, M. Urabe, F. Masui, T. Ebisawa, A. Tezuka, K. Iwasawa, T. Nakajima, et al. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: A scheme for the progression of cardiac dysfunction PNAS, May 11, 2004; 101(19): 7381 - 7385. [Abstract] [Full Text] [PDF]
|
|